CG MedTech Co

CG MedTech Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of CG MedTech Co (056090.KQ) as of Nov 19, 2026 is 40.15 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 2,530.79 % — a change of -98.41% (lower).

Cash Conversion

40.15 %

YoY

-98.41%

Last updated:

Cash Conversion Rate (OCF/Net Income) of CG MedTech Co is 2025 40.15 % . Cash Conversion Rate (OCF/Net Income) of CG MedTech Co was 2024 2,530.79 % . It decreases by -98.41% lower compared to the previous year.

The CG MedTech Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
20.07 KRW
Jan 1, 2019
111.73 KRW
Jan 1, 2020
-17.50 KRW
Jan 1, 2021
-25.85 KRW
Jan 1, 2022
28.94 KRW
Jan 1, 2023
-152.13 KRW
Jan 1, 2024
2,530.79 KRW
Jan 1, 2025
40.15 KRW
The CG MedTech Co Cash Conversion history
YEARCash ConversionYoY
40.15 %-98.41%
2,530.79 %-1,763.59%
-152.13 %-625.72%
28.94 %-211.96%
-25.85 %+47.66%
-17.50 %-115.67%
111.73 %+456.60%
20.07 %-14.75%
23.55 %-86.19%
170.56 %-68.67%
544.32 %+1,031.48%
48.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Cash Conversion Rate (OCF/Net Income) of CG MedTech Co is 40.15 % in 2025.

Cash Conversion Rate (OCF/Net Income) of CG MedTech Co changed from 2,530.79 % to 40.15 %, representing a -98.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s CG MedTech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CG MedTech Co

All Key Metrics — CG MedTech Co